Author Archives: admin


Global Umbilical Cord Blood (UCB) Stem Cell Market 2020 Industry Size and Share Evolution to 2026 by Growth Insight, Product Demand, Scope, Key…

Umbilical Cord Blood (UCB) Stem Cell Market Global Research Report 2020 is a comprehensive business study on the current state of industry which analyses innovative strategies for business growth and describes important factors such as top manufacturers, production value, key regions, and growth rate. The Umbilical Cord Blood (UCB) Stem Cell Industry report also presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market.

Get Sample Copy of this Report https://prominentmarketresearch.com/sample-report/125927

The Umbilical Cord Blood (UCB) Stem Cell Market report comprises a detailed value chain analysis, which provides a comprehensive view of the global market. The Porters Five Forces model for the market has also been included to help understand the competitive landscape in the Umbilical Cord Blood (UCB) Stem Cell market.

The report also highlights opportunities and future scope in the Umbilical Cord Blood (UCB) Stem Cell market at the global and regional level. The study encompasses market attractiveness analysis, wherein the service is benchmarked based on market size, growth rate, and general Umbilical Cord Blood (UCB) Stem Cell industry share.

This report focuses on the global Umbilical Cord Blood (UCB) Stem Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Umbilical Cord Blood (UCB) Stem Cell development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://prominentmarketresearch.com/inquiry-report/125927

The study includes profiles of major companies operating in the global Umbilical Cord Blood (UCB) Stem Cell market. Market players have been profiled in terms of attributes such as company overview, financial overview, business strategies, and recent developments.

Regional analysis is another highly comprehensive part of the research and analysis study of the global Umbilical Cord Blood (UCB) Stem Cell market presented in the report. This section sheds light on the sales growth of different regional and country-level Umbilical Cord Blood (UCB) Stem Cell markets.

The key regions and countries covered in this report are:

Market segment by Type, the product can be split intoStem Cell TransplantAutologous TransplantAllogenic TransplantTransplant MedicineRegenerative MedicineOthersMarket segment by Application, split intoTherapeutics Service CompaniesPrivate And Government Research InstitutesAcademic InstitutesResearch Based Pharmaceutical CompaniesPublic And Private Cord Blood BanksOthers

In order to compile the Umbilical Cord Blood (UCB) Stem Cell market research report, we conducted in-depth interviews and discussions with a number of key industry participants and opinion leaders.

We reviewed key players product literature, annual reports, press releases, and relevant documents for competitive analysis and Umbilical Cord Blood (UCB) Stem Cell market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, statistics data from government websites, trade associations, and agencies.

This has proven to be the most reliable, effective, and successful approach for obtaining precise market data, capturing industry participants insights, and recognizing business opportunities.

Get Complete Report in Your Inbox @ https://prominentmarketresearch.com/checkout/125927

Umbilical Cord Blood (UCB) Stem Cell Market Key Stakeholders:

Key Points from Table of Content:

1 Umbilical Cord Blood (UCB) Stem Cell Market Overview

2 Global Umbilical Cord Blood (UCB) Stem Cell Market Competition by Manufacturers

3 Global Umbilical Cord Blood (UCB) Stem Cell Capacity, Production, Revenue (Value) by Region (2015-2020)

4 Global Umbilical Cord Blood (UCB) Stem Cell Supply (Production), Consumption, Export, Import by Region (2015-2020)

5 Global Umbilical Cord Blood (UCB) Stem Cell Production, Revenue (Value), Price Trend by Type

6 Global Umbilical Cord Blood (UCB) Stem Cell Market Analysis by Application

7 Global Umbilical Cord Blood (UCB) Stem Cell Manufacturers Profiles/Analysis

8 Umbilical Cord Blood (UCB) Stem Cell Manufacturing Cost Analysis

9 Umbilical Cord Blood (UCB) Stem Cell Industrial Chain, Sourcing Strategy and Downstream Buyers

10 Umbilical Cord Blood (UCB) Stem Cell Marketing Strategy Analysis, Distributors/Traders

11 Umbilical Cord Blood (UCB) Stem Cell Market Effect Factors Analysis

12 Global Umbilical Cord Blood (UCB) Stem Cell Market Forecast (2020-2026)

13 Umbilical Cord Blood (UCB) Stem Cell Market Research Findings and Conclusion

14 Appendix

If you need anything more than these then let us know and we will prepare the report according to your requirement.

About Us

Prominent Market Research has an extensive coverage of diligence verticals of qualitative and quantitative reports across all the industries. In case your needs are not met by syndicated reports untaken by the foremost publishers, we can help you by proposing a customized research elucidation by liaising with different research interventions saving your valuable time and money. We have experienced and trained staff that helps you navigate different options and lets you choose preeminent research solution at most effective cost.

Contact Us

Michael, Sales Manager

Prominent Market Research

7309 Woodward Ave,

Apt 107, Woodridge, Illinois, USA, 60517

Phone: USA +1-630-361-6262

Email: [emailprotected]

Corporate Sales: [emailprotected]

More:
Global Umbilical Cord Blood (UCB) Stem Cell Market 2020 Industry Size and Share Evolution to 2026 by Growth Insight, Product Demand, Scope, Key...

Stem Cell Banking Market Rising Trends and Technology Outlook 2020 to 2026 Cordlife Group Limited, CordVida, Cryo-Cell International, ESPERITE N.V. -…

The latest report on the global Stem Cell Banking market research offers a powerful estimation related to the Stem Cell Banking market dynamics. This report also sheds light on a variety of elements such as product types and its specifications, applications and elite players. Apart from this, the research document on the global Stem Cell Banking market has been segmented on the basis of crucial elements like major companies, Stem Cell Banking development areas, item types, which will definitely offer a detailed and informative overview about the overall Stem Cell Banking industry. Moreover, it also explains a wide range of components including leading players strategy in terms of the company profile, sales earnings, customer needs and the business-related tactics used in the Stem Cell Banking market that allows you to take essential business-related decisions.

sample copy of Stem Cell Banking report at: https://calibreresearch.com/report/global-stem-cell-banking-market-1270#request-sample

The worldwide Stem Cell Banking market report is considered as a detailed investigation of the respective market that will provide key solutions for establishment of profit-driven business strategies. It is helpful for offering details about futuristic Stem Cell Banking industry trends and in-depth assessment of the international industry. It permits you to determine remarkable challenges and risk factors alongside major opportunities available in the world Stem Cell Banking market. This report also exhibits the whole historical and current status of the Stem Cell Banking market globally. Apart from this, the report on the Stem Cell Banking industry also represents the graphical representation of the upcoming Stem Cell Banking market infrastructure and the compound annual growth rate(CAGR) in detail.

The study on the Stem Cell Banking market demonstrates a list of essential perspectives and innovative ideas required to make a brand new plan for uplifting the growth of the world Stem Cell Banking market. The research report on the global Stem Cell Banking market 2020- 2026 covers all the comprehensive aspects related to the universal industry that makes use of several analytical tools and methods. It promises to offer data about the recent developments while analyzing the growth of the forthcoming worldwide Stem Cell Banking market vendors. Meanwhile, it also includes substantial statistics like product specifications, revenue share, a detailed survey of predominant players and brief segmentation of the global Stem Cell Banking industry.

Stem Cell Banking Manufacturers Companies in this market are:

Amag Pharmaceuticals, Inc.Americord Registry LLCChina Cord Blood CorporationCord Blood America, Inc.Cordlife Group LimitedCordVidaCryo-Cell International, Inc.Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V.ESPERITE N.V.Lifeforce Cryobank Sciences, Inc.

The Stem Cell BankingThe Stem Cell Banking Market market report is segmented into following categories:

Cell Type SegmentUmbilical Cord Stem CellCord BloodCord TissuePlacentaAdult Stem CellEmbryonic Stem CellBank Type SegmentPublicPrivateService Type SegmentCollection & TransportationProcessingAnalysisStorageUtilization SegmentUsedUnused

The research study on the Stem Cell Banking market is a valuable source of guidance for global customers as it will rapidly fulfil their requirement and speed up their business growth. It is an advantageous document for both existing industries manufactures including end-user industries, experts, managers, stakeholders and new entrants. We have designed this global Stem Cell Banking market report in a deeply understandable format so that anyone can grasp each and every aspect related to the respective industry.

More Details about Stem Cell Banking report https://calibreresearch.com/report/global-stem-cell-banking-market-1270

In this study, our experts have briefly analyzed and reviewed some extremely significant facets regarding the world Stem Cell Banking market to project industrial growth of the international marketplace. This report has been crafted through numerous primary as well as secondary research techniques that allow you to gain Stem Cell Banking market growth with a clear understanding of business-related components and competitive landscape. Leading members such as CEOs, CFOs, analysts, supply-chain members, B2B clients and suppliers are involved in this newly formed research study.

More:
Stem Cell Banking Market Rising Trends and Technology Outlook 2020 to 2026 Cordlife Group Limited, CordVida, Cryo-Cell International, ESPERITE N.V. -...

Animal Cell Culture Market Size 2020 Analysis By Industry Share, Business Strategies, Emerging Demands, Growth Rate, Recent Trends, Opportunity, and…

The report titled Global Animal Cell Culture Market has covered and analysed the potential of Worldwide Animal Cell Culture Industry and provides statistics and information on market dynamics, growth factors, key challenges, major drivers & restraints, opportunities and forecast 2026.

Get a sample copy of the report at - https://www.industryresearch.biz/enquiry/request-sample/15168068

Global Animal Cell Culture Market 2020 Research report provides information regarding Animal Cell Culture market size, trends, growth, cost structure, capacity, revenue and forecast 2026. This report also includes the overall and comprehensive study of the Animal Cell Culture Market share with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Animal Cell Culture industry and provides data for making strategies to increase Animal Cell Culture market growth and effectiveness.

The Global Animal Cell Culture market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Animal Cell Culture market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The objective of this report:

Enquire before purchasing this report - https://www.industryresearch.biz/enquiry/pre-order-enquiry/15168068

Global Animal Cell Culture market competition by TOP MANUFACTURERS, with production, price, revenue (value) and each manufacturer including

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

Global Animal Cell Culture Market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and instrumentation and downstream demand analysis is additionally dispensed. The Global Animal Cell Culture market development trends and marketing channels are analyzed. Finally, the feasibility of latest investment projects is assessed and overall analysis conclusions offered.

Purchase this report (Price 3400 USD for a single-user license) - https://www.industryresearch.biz/purchase/15168068

Years considered for this report:

With tables and figures helping analyse worldwide Global Animal Cell Culture market trends, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Some Points from TOC:

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Regulatory Scenario by Region/Country1.4 Market Investment Scenario Strategic1.5 Market Analysis by Type1.5.1 Global Animal Cell Culture Market Share by Type (2020-2026)1.5.2 Type 11.5.3 Type 21.5.4 Other1.6 Market by Application1.6.1 Global Animal Cell Culture Market Share by Application (2020-2026)1.6.2 Application 11.6.3 Application 21.6.4 Other

2. Global Market Growth Trends2.1 Industry Trends2.1.1 SWOT Analysis2.1.2 Porters Five Forces Analysis2.2 Potential Market and Growth Potential Analysis2.3 Industry News and Policies by Regions2.3.1 Industry News2.3.2 Industry Policies

3 Value Chain of Animal Cell Culture Market3.1 Value Chain Status3.2 Animal Cell Culture Manufacturing Cost Structure Analysis3.2.1 Production Process Analysis3.2.2 Manufacturing Cost Structure of Animal Cell Culture3.2.3 Labor Cost of Animal Cell Culture3.3 Sales and Marketing Model Analysis3.4 Downstream Major Customer Analysis (by Region)

4 Players Profiles4.1 Player 14.1.1 Player 1 Basic Information4.1.2 Animal Cell Culture Product Profiles, Application and Specification4.1.3 Player 1 Animal Cell Culture Market Performance (2015-2020)4.1.4 Player 1 Business Overview

4.2 Player 24.2.1 Player 2 Basic Information4.2.2 Animal Cell Culture Product Profiles, Application and Specification4.2.3 Player 2 Animal Cell Culture Market Performance (2015-2020)4.2.4 Player 2 Business Overview

4.3 Player 34.3.1 Player 3 Basic Information4.3.2 Animal Cell Culture Product Profiles, Application and Specification4.3.3 Player 3 Animal Cell Culture Market Performance (2015-2020)4.3.4 Player 3 Business Overview

4.4 Player 44.4.1 Player 4 Basic Information4.4.2 Animal Cell Culture Product Profiles, Application and Specification4.4.3 Player 4 Animal Cell Culture Market Performance (2015-2020)4.4.4 Player 4 Business Overview

4.5 Player 54.5.1 Player 5 Basic Information4.5.2 Animal Cell Culture Product Profiles, Application and Specification4.5.3 Player 5 Animal Cell Culture Market Performance (2015-2020)4.5.4 Player 5 Business Overview5 Global Animal Cell Culture Market Analysis by Regions5.1 Global Animal Cell Culture Sales, Revenue and Market Share by Regions5.1.1 Global Animal Cell Culture Sales by Regions (2015-2020)5.1.2 Global Animal Cell Culture Revenue by Regions (2015-2020)5.2 North America Animal Cell Culture Sales and Growth Rate (2015-2020)5.3 Europe Animal Cell Culture Sales and Growth Rate (2015-2020)5.4 Asia-Pacific Animal Cell Culture Sales and Growth Rate (2015-2020)5.5 Middle East and Africa Animal Cell Culture Sales and Growth Rate (2015-2020)5.6 South America Animal Cell Culture Sales and Growth Rate (2015-2020)

11 Global Animal Cell Culture Market Segment by Types12 Global Animal Cell Culture Market Segment by Applications13 Animal Cell Culture Market Forecast by Regions (2020-2026)Continued

Detailed TOC of Global Animal Cell Culture Market @ https://www.industryresearch.biz/TOC/15168068

About Us:

Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided todays businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Industry Research is the credible source for gaining the market reports that will provide you with the lead your business needs.

Contact Info:

Name : Mr. Ajay More

E-mail : [emailprotected]

Organization : Industry Research Biz

Phone: US +1424 253 0807 / UK +44 203 239 8187

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Animal Cell Culture Market Size 2020 Analysis By Industry Share, Business Strategies, Emerging Demands, Growth Rate, Recent Trends, Opportunity, and Forecast To 2026

ExpressWire

Visit ExpressWire's Website

See the original post here:
Animal Cell Culture Market Size 2020 Analysis By Industry Share, Business Strategies, Emerging Demands, Growth Rate, Recent Trends, Opportunity, and...

Stem Cell Cartilage Regeneration Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2026 – Redhill Local Councillors

The Stem Cell Cartilage Regeneration Market is expected to have a highly positive outlook for the next eight years 2019-2026. This Research Reports emphasizes on key industry analysis, market size, Share, growth and extensive industry dynamics with respect to with respect to drivers, opportunities, pricing details and latest trends in the industry.

The global Stem Cell Cartilage Regeneration Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Stem Cell Cartilage Regeneration Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.

Download Free PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2448

Geographical segmentation of Stem Cell Cartilage Regeneration Market involves the regional outlook which further covers United States, China, Europe, Japan, Southeast Asia and Middle East & Africa. This report categorizes the market based on manufacturers, regions, type and application.

Stem Cell Cartilage Regeneration Market: Competitive Landscape

Leading players operating in the global market include: Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.

Scope of the Report

The key features of the Stem Cell Cartilage Regeneration Market report 2019-2026 are the organization, extensive amount of analysis and data from previous and current years as well as forecast data for the next five years. Most of the report is made up from tables, charts and figures that give our clients a clear picture of the Market.

As the report proceeds further, it covers the analysis of key market participants paired with development plans and policies, production techniques, price structure of the Stem Cell Cartilage Regeneration Market. The report also identifies the other essential elements such as product overview, supply chain relationship, raw material supply and demand statistics, expected developments, profit and consumption ratio.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2448

Important Stem Cell Cartilage Regeneration Market Data Available In This Report:

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

For More Related Reports Visit This Blog: http://bit.ly/Rajkumar123

Continued here:
Stem Cell Cartilage Regeneration Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2026 - Redhill Local Councillors

Cancer Stem Cell Therapy Market Outlook, Recent Trends and Growth Forecast 2020- – News by aeresearch

New 2019 Report onCancer Stem Cell Therapy Market size | Industry Segment by Applications (Hospital, Clinic, Medical Research Institution and Other), by Type (Autologous Stem Cell Transplants, Allogeneic Stem Cell Transplants, Syngeneic Stem Cell Transplants and Other), Regional Outlook, Market Demand, Latest Trends, Cancer Stem Cell Therapy Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025.Analyzes current market size and upcoming 5 years growth of this industry.

The report on Cancer Stem Cell Therapy market strive to provide business professionals with an updated information on Cancer Stem Cell Therapy market, high growth markets, emerging business environments and latest business-centric applications. The Cancer Stem Cell Therapy market Analysis report provides a detailed analysis of sales channel and regional analysis of the Cancer Stem Cell Therapy market.

Likewise, Cancer Stem Cell Therapy Market report also assesses the key opportunities in the Cancer Stem Cell Therapy market and outlines the factors that are and will be driving the growth of the Cancer Stem Cell Therapy market share in current industry. The Cancer Stem Cell Therapy report is analyzed and forecasted for the previous and next five years of industry.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/83954

The key Cancer Stem Cell Therapy market players are weighed on a variety of factors such as company overview, product portfolios and recent development of the global Cancer Stem Cell Therapy market.

Top key playersof industry are covered in Cancer Stem Cell Therapy Market Research Report:

Split by product type,with production, revenue, price, market share and growth rate of each type, can be divided into:

Split by application,this report focuses on consumption, market share and growth rate of Cancer Stem Cell Therapy market in each application and can be divided into:

The predictions highlighted in the Cancer Stem Cell Therapy market share report have been derived using verified research procedures and assumptions. By doing so, the research report serves as a repository of analysis and information for every component of the Cancer Stem Cell Therapy market. Across the past few years, the Cancer Stem Cell Therapy have seen the rise of influential market leaders in the space. The competition in the global Cancer Stem Cell Therapy market is dominated by the big players: AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics and Silicon Biosystems

The Cancer Stem Cell Therapy market has shown growing trends over the years and anticipations are made that the Cancer Stem Cell Therapy market size would grow at a speedy pace in the upcoming years. Growth in the Cancer Stem Cell Therapy market would be primarily driven by application areas such as Hospital, Clinic, Medical Research Institution and Other and product types segment like Autologous Stem Cell Transplants, Allogeneic Stem Cell Transplants, Syngeneic Stem Cell Transplants and Other.

Outline of Cancer Stem Cell Therapy Market report covers:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/83954

Originally posted here:
Cancer Stem Cell Therapy Market Outlook, Recent Trends and Growth Forecast 2020- - News by aeresearch

Mixed ethnic backgrounds make it that much harder to find a bone marrow transplant – MLive.com

ANN ARBOR, MI They searched the world for a match.

Bennett Sevack needed a bone marrow transplant. He was diagnosed with myelodysplastic syndrome after treatment for chronic lymphocytic leukemia. But there was no match for the Ann Arbor resident in the international registry.

So, his family started making calls.

Doctors first tried his siblings and cousins. When that didnt work, his sisters, friends and family spent six weeks calling and sharing flyers with synagogues around the world to encourage people to join the bone marrow registry, hoping someone with Sevacks Sephardic and Ashkenazi Jewish background would be willing to donate.

By fall, a partial match was found in an Italian obstetrics hospital in an umbilical cord blood sample. Soon after, another cord blood match was found in the U.S. It was enough to perform a transplant.

Sevack has gained an intense appreciation for donors.

You can save somebodys life..." he said. Its a blessing to do.

Finding an acceptable bone marrow donor is a challenge in general, but its that much harder for people of color and patients of complex ethnic backgrounds like Sevack, according to health care providers and families whove embarked on far-reaching searches for a match.

A white person has a 77% shot at finding a matching donor, according to Be The Match, a widely used donor registry. A black persons chances are 23%. For people of mixed backgrounds, the search can become more complex.

Part of the issue is the relatively narrow population of donors in the registry. Another part is the science: Certain HLA types, the protein that needs to match in bone marrow transplants, are more unique to specific backgrounds.

A closer look at plans for the new $920M University of Michigan hospital

Sevacks transplant was completed in October 2019 more than three years after his initial diagnosis, and four months after getting news that he would definitely need a transplant.

He spent eight weeks healing from his transplant and two weeks healing from a bout of graft-versus-host disease in the hematology oncology clinic on the seventh floor of Ann Arbors C.S. Mott Childrens Hospital.

On the same floor, a 9-year-old Ann Arbor-area patient undergoing chemotherapy for acute myeloid leukemia is in the same predicament that Sevack once faced. She may need a bone marrow transplant as well, but a donor match her ethnic background is Cantonese, Hispanic and Caucasian has yet to be found in the registry.

The search

Genetics play a major role in finding a good match, said Mark Vander Lugt, a pediatric bone marrow transplant specialist at C.S. Mott working with the 9-year-old. People get four HLA types from each parent, meaning donors need to match in at least six spots, though sometimes a stronger match is required.

You get combinations that are hard to find in the registry because of that, Vander Lugt said.

Not everyone needs a transplant once theyre diagnosed. Doctors often treat blood cancers and related illnesses with chemotherapy first killing off the bad cells and waiting to see if healthy cells regenerate. If they dont, a transplant replaces the bone marrow, where blood stem cells are made.

Mothers breast cancer pushes Ypsilanti woman to get preventative mastectomy

The registry is so low on certain populations that some began taking matters into their own hands. Athena Asklipiadis founded Mixed Marrow, a nonprofit that conducts outreach to encourage multi-ethnic bone marrow and blood cell donations. She said the misconceptions of donation is one of the largest challenges in getting people registered. She started by reaching out to Facebook groups and college clubs on the West Coast, where she is based. Eventually, families began reaching out to her to help in the donor search.

People use this phrase, When theres a cure for cancer or If theres a cure for cancer, Asklipiadis said. But these are actual blood diseases and cancers that are curable. Theyre curable by the selflessness of a donor and thats the beautiful thing about it.

Sevacks sister Laurel Bernstein was part of the group of relatives and supporters who called synagogues in search of donors. She estimated they called hundreds of people and added more than 1,000 to the donor registry while searching for Sevacks match.

The nine of us all felt so energized by what happened, Bernstein said. "We had not finished calling the list, even though we got the match. We went through to the end of the list to help pay it forward, to help other people, to get that much more DNA into the database.

The transplant

For Sevack, it was umbilical cord blood that saved his life. DNA from the two samples created enough HLA type matches to begin the transplant.

Vander Lugt said the preferred transplant method is still donor transplants, because cord blood units are smaller and in more limited supply than donor cells.

Misconceptions of transplants are another roadblock. A bone marrow harvest in which a donor undergoes surgery to collect marrow from the hip is widely believed to be painful. But experts describe the process as a mild discomfort with a two-to-three day recovery time, instead.

And direct harvest is no longer the only method. Many hospitals also practice apheresis, which collects the peripheral blood that can generate new bone marrow through a process that looks like dialysis. Theres no surgery involved.

Choosing between the two collection processes is based on multiple factors, including the health of the patient undergoing general anesthesia and doctor and donor preference, Vander Lugt said.

The value

Fear of the unknown is what affected Sevack the most going into treatment. He said he had an anxiety breakdown the morning of his transplant, when he realized what was about to happen.

My heart was to the moon, Sevack said. I was fully dressed and every part of me was drenched. In about eight minutes I had gone through this journey of fear because the reality of what was going to come was upon me. (My wife) calmed me down, I changed my clothes and this journey began. Theres been plenty of times when Ive been scared to death.

Finding a transplant match taught his wife Phyllis Sevack the importance of facing each day separately. Fighting cancer was about healing every day making big battles smaller.

The reality of it hits all at once, Phyllis Sevack said. "I wouldnt want anybody to be afraid to go through it because it is every day take it day by day. And as soon as Bennett got over that hes not doing everything on one day, (he got better mentally).

Now at home, Bennett Sevack may take a year to fully heal. He looks forward to small improvements in his quality of life, like an expanded diet and doing his own grocery shopping at Meijer, he said.

Even the routine blood and platelet donations he received in treatment were invaluable to him. They saved his life.

Where to donate blood in Washtenaw County during shortage

Every day, theyd give me sacks of stuff that made me sick to think about it, Sevack said. It was someones donation that was given, that was literally giving me life. People who donate would do an amazing service to someone. You may not know who that is but its somebody.

Potential donors can begin the registration process by filling out a questionnaire about their medical history at bethematch.org. A cheek swab will confirm whether you meet the medical guidelines for donation. You may remain on the registry for years before a match is found. More information is available here.

Wolverines for Life and the Michigan Medicine Bone Marrow Transplant department are hosting a registration drive from 10:30 a.m. to 5 p.m. Tuesday, Feb. 18 at the Pierpoint Commons lobby, 2101 Bonisteel Blvd., Ann Arbor.

See the original post here:
Mixed ethnic backgrounds make it that much harder to find a bone marrow transplant - MLive.com

48% of Couples Are Making This Financial Mistake – Nasdaq

"Now it's true I married my wife for her looks ... but not the ones she's been giving me lately."

-- Comedian Jeff Foxworthy

If you've been sharing raised eyebrows and evil stares with your spouse lately, a financial disagreement is a likely cause. Money is routinely cited as a common source of friction between spouses, but there are steps you can take to change that.

A 2019 survey by Northwestern Mutual and wedding planning website The Knot questioned married folks on their views about money and budgeting. Some 40% of those respondents cited financial stability as their greatest long-term worry, making it a more prominent concern than raising children and maintaining intimacy in their relationship. But surprisingly, 48% of respondents said they weren't reviewing finances weekly with their spouse. And 22% admitted to having budgeting disagreements with their partner each month.

Image source: Getty Images.

An open line of communication between spouses about money can head off arguments by ensuring both partners are on the same page about their money and financial goals. Here are five essential strategies to kick off money-planning sessions with your spouse.

Start your money talks by sharing and prioritizing long-term financial goals. An obvious starting point is retirement. Discuss how each of you envisions life after work. Then address other common goals, such as funding college for the kids or buying a new home. Keep the conversation going to talk through "wish list" goals, too. Is there the chance one of you might start a business in the future? Does your spouse secretly want to buy a boat someday? Nothing is off the table.

Write down these goals and, together, rank them in priority. Next, you'll build a budget to start moving toward those goals.

Budgeting begins with knowing what your lifestyle costs you today. Write down all of your shared and required expenses. These include rent or mortgage payments, property taxes, utilities, food, car payments, gas, and insurance.

Ideally, these should total about 50% of your combined take-home pay. If the percentage is higher than that, explore ways to reduce your costs. Often, food is the easiest place to trim spending: You could start cutting coupons or only buy items that are on sale, for example. If you need to make larger cuts, brainstorm what's possible. Could you move to a cheaper neighborhood, downsize your cars, or bundle your insurance plans to save?

Discretionary spending can be a point of contention for couples. Maybe your spouse spends $200 monthly on streaming services plus cable, while you'd be happy with a $10 monthly subscription to Kindle Unlimited. There is no universal solution to solve these differences, but you can and should define a system that works for the two of you.

If you have your required expenses down to 50% of your combined take-home pay, you can afford to spend another 30% on nonessentials. Split that 30% up in whatever way makes sense for your situation. Most of the time, it's logical to allocate 10% to each of you and 5% to shared discretionary expenses. In this framework, you each can make nonessential buying decisions as long as you stay within your 10%.

For this system to work, you'll have to talk through which expenses belong to you and which belong to your partner. If you both go to the gym, for example, that's a shared expense. But other items, like cable, may not be clear-cut. Perhaps your spouse feels strongly about having access to HGTV and you are indifferent to cable. If your spouse takes responsibility for that bill, it doesn't mean you must look away whenever House Hunters is on.

The goal isn't to be territorial. It's to provide a framework that gives each of you some financial decision-making rights within the relationship. If you play within the rules, you can each spend on things that are important to you.

At this point, you've allocated 50% of your take-home pay to required expenses and 30% to the nonessentials. That leaves 20% available for debt payments and long-term financial goals. Experts recommend you save 15% to your retirement accounts. Of course, if you have high debt levels or other financial goals to fulfill before retirement, that 15% may not be possible. Save at least enough to your 401(k) to maximize your company-match contributions and decide together how to allocate the rest.

Now comes the hard part. Set a recurring day and time for the two of you to review your spending. The first few sessions will probably reveal some holes in your budget and some misunderstandings about what's a shared expense and what's not. That's part of the process. Make adjustments to the budget and your spending rules until you land on a system that's sustainable. Remember that the two of you are on the same team, working toward the same list of prioritized goals.

There's one final rule about these money-planning sessions: Leave the cold stares at the door. You'll both make spending mistakes and together you'll face unexpected expenses. Don't let these derail you from your shared plan. Just rework the budget and keep pressing on toward those long-term goals.

The $16,728 Social Security bonus most retirees completely overlook If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income. For example: one easy trick could pay you as much as$16,728 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after.Simply click here to discover how to learn more about these strategies.

The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Read the original post:
48% of Couples Are Making This Financial Mistake - Nasdaq

Surge in the Adoption of Stem Cell-Derived Cells to Fuel the Growth of the Stem Cell-Derived Cells Market Through the Assessment Period 2019 2029 -…

The comprehensive report published by Persistence Market Research offers an in-depth intelligence related to the various factors that are likely to impact the demand, revenue generation, and sales of the Stem Cell-Derived Cells Market. In addition, the report singles out the different parameters that are expected to influence the overall dynamics of the Stem Cell-Derived Cells Market during the forecast period 2019 2029.

As per the findings of the presented study, the Stem Cell-Derived Cells Market is poised to surpass the value of ~US$ XX by the end of 2029 growing at a CAGR of ~XX% over the assessment period. The report includes a thorough analysis of the upstream raw materials, supply-demand ratio of the Stem Cell-Derived Cells in different regions, import-export trends and more to provide readers a fair understanding of the global market scenario.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) athttps://www.persistencemarketresearch.co/samples/28780

The report segregates the Stem Cell-Derived Cells Market into different segments to provide a detailed understanding of the various aspects of the market. The competitive analysis of the Stem Cell-Derived Cells Market includes valuable insights based on which, market players can formulate impactful growth strategies to enhance their presence in the Stem Cell-Derived Cells Market.

Key findings of the report:

The report aims to eliminate the following doubts related to the Stem Cell-Derived Cells Market:

Get Access To TOC Covering 200+ Topics athttps://www.persistencemarketresearch.co/toc/28780

key players in stem cell-derived cells market are focused on generating high-end quality cardiomyocytes as well as hepatocytes that enables end use facilities to easily obtain ready-made iPSC-derived cells. As the stem cell-derived cells market registers a robust growth due to rapid adoption in stem cellderived cells therapy products, there is a relative need for regulatory guidelines that need to be maintained to assist designing of scientifically comprehensive preclinical studies. The stem cell-derived cells obtained from human induced pluripotent stem cells (iPS) are initially dissociated into a single-cell suspension and later frozen in vials. The commercially available stem cell-derived cell kits contain a vial of stem cell-derived cells, a bottle of thawing base and culture base.

The increasing approval for new stem cell-derived cells by the FDA across the globe is projected to propel stem cell-derived cells market revenue growth over the forecast years. With low entry barriers, a rise in number of companies has been registered that specializes in offering high end quality human tissue for research purpose to obtain human induced pluripotent stem cells (iPS) derived cells. The increase in product commercialization activities for stem cell-derived cells by leading manufacturers such as Takara Bio Inc. With the increasing rise in development of stem cell based therapies, the number of stem cell-derived cells under development or due for FDA approval is anticipated to increase, thereby estimating to be the most prominent factor driving the growth of stem cell-derived cells market. However, high costs associated with the development of stem cell-derived cells using complete culture systems is restraining the revenue growth in stem cell-derived cells market.

The global Stem cell-derived cells market is segmented on basis of product type, material type, application type, end user and geographic region:

Segmentation by Product Type

Segmentation by End User

The stem cell-derived cells market is categorized based on product type and end user. Based on product type, the stem cell-derived cells are classified into two major types stem cell-derived cell kits and accessories. Among these stem cell-derived cell kits, stem cell-derived hepatocytes kits are the most preferred stem cell-derived cells product type. On the basis of product type, stem cell-derived cardiomyocytes kits segment is projected to expand its growth at a significant CAGR over the forecast years on the account of more demand from the end use segments. However, the stem cell-derived definitive endoderm cell kits segment is projected to remain the second most lucrative revenue share segment in stem cell-derived cells market. Biotechnology and pharmaceutical companies followed by research and academic institutions is expected to register substantial revenue growth rate during the forecast period.

North America and Europe cumulatively are projected to remain most lucrative regions and register significant market revenue share in global stem cell-derived cells market due to the increased patient pool in the regions with increasing adoption for stem cell based therapies. The launch of new stem cell-derived cells kits and accessories on FDA approval for the U.S. market allows North America to capture significant revenue share in stem cell-derived cells market. Asian countries due to strong funding in research and development are entirely focused on production of stem cell-derived cells thereby aiding South Asian and East Asian countries to grow at a robust CAGR over the forecast period.

Some of the major key manufacturers involved in global stem cell-derived cells market are Takara Bio Inc., Viacyte, Inc. and others.

The report covers exhaustive analysis on:

Regional analysis includes

Report Highlights:

In order to get a strategic overview of the market,Access Research Methodology Prepared By Experts athttps://www.persistencemarketresearch.co/methodology/28780

Reasons to buy from PMR

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact us:

Persistence Market Research

305 Broadway, 7th Floor

New York City, NY 10007

United States

Ph.no. +1-646-568-7751

Tags: Stem CStem Cell-Derived Cells MarketStem Cell-Derived Cells Market DynamicsStem Cell-Derived Cells Market GrowthStem Cell-Derived Cells Market KeyplayersStem Cell-Derived Cells Market Trends

See the rest here:
Surge in the Adoption of Stem Cell-Derived Cells to Fuel the Growth of the Stem Cell-Derived Cells Market Through the Assessment Period 2019 2029 -...

The 411 on Stem Cells: What They Are and Why It’s Important to Be Educated – Legal Examiner

Medical treatment involving stem cells is an ever-growing, billion-dollar industry, so chances are you have heard about it in the news. Here in the U.S. and around the world, stem cells are being used in various therapies to treat a wide variety of health problems and diseases, including dementia, autism, multiple sclerosis, cerebral palsy, osteoarthritis, cancer, heart disease, Parkinsons disease, and spinal cord injury. Treatments for such health issues may sound promising, but the risk is many of those being sold and advertised arent yet proven to be safe and effective. This is why its so important to educate yourself before jumping into any kind of stem cell treatment.

What are stem cells?

To gain a better understanding of this new age of medical research, one must first understand what stem cells are and how they work. Stem cells are special human cells that can develop into many different types of cells. They can divide and produce more of the same type of stem cells, or they can turn into different functioning cells. There are no other types of cells in the body that have this natural ability to generate new cell types.

Where do stem cells come from?

So where do stem cells that are used for research and medical treatments come from? The three main types of stem cells are embryonic (or pluripotent) stem cells, adult stem cells, and induced pluripotent stem cells.

Embryonic stem cells come from unused, in vitro fertilized embryos that are three to five days old. The embryos are only donated for research purposes with the informed consent of the donors. Embryonic stem cells are pluripotent, which means they can turn into any cell type in the body.

Adult stem cells are found in small numbers in developed tissues in different parts of the body, such as bone marrow, skin, and the brain. They are specific to a certain kind of tissue in the body and are limited to maintaining and repairing the tissue in which they are found. For example, liver stem cells can only make new liver tissue; they arent able to make new muscle tissue.

Induced pluripotent stem cells are another form of adult stem cells. These are stem cells that have been manipulated in a laboratory and reprogrammed to work like embryotic (or pluripotent) stem cells. While these altered adult stem cells dont appear to be clinically different from embryonic stem cells, research is still being conducted to determine if the effects they have on humans differ from actual embryonic stem cells.

Stem cells can also be found in amniotic fluid and umbilical cord blood. These stem cells have the ability to change into specialized cells like embryonic stem cells. While more research is being conducted to determine the potential of these types of stem cells, researchers already actively use these through amniocentesis procedures. In this procedure, the stem cells drawn from amniotic fluid samples of pregnant women can be screened for developmental abnormalities in a fetus.

How stem cells function

The main difference between embryonic and adult stem cells is how they function. Embryonic stem cells are more versatile. Since they can divide into more stem cells or become any type of cell in the body, they can be used to regenerate or repair a variety of diseased tissue and organs. Adult stem cells only generate the types of cells from where they are taken from in the body.

The future of stem cell research

The ability for stem cells to regenerate under the right conditions in the body or in a laboratory is why researchers and doctors have become so interested in studying them. Stem cell research is helping scientists and doctors to better understand how certain diseases occur, how to possibly generate healthy cells to replace diseased cells, and offer ways to test new drugs.

Clearly, stem cell research is showing great potential for understanding and treating a range of diseases and other health issues, but there is still a lot to learn. While there are some diseases that are showing success using stem cell treatments, many others are yet to be proven in clinical trials and should be considered highly experimental.

In our next article, various stem cell treatments, FDA regulations, and other stem cell hot topics will be explored. It will also focus on what to look for when considering stem cell therapies so people arent misled or misinformed about the benefits and risks.

For more information regarding the basics of stem cells visit these sites:

https://stemcells.nih.gov/info/basics/1.htm

https://www.mayoclinic.org/tests-procedures/bone-marrow-transplant/in-depth/stem-cells/art-20048117

Read more:
The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner

Will Cultured Meat Soon Be A Common Sight In Supermarkets Across The Globe? – Forbes

A hamburger made out of cell-based meat by Mosa Meat, one of many companies throughout the world ... [+] creating beef and other animal products without the animal.

Up until now, plant-based food companies like Beyond Meat, Impossible Foods, and Quorn have almost singlehandedly worked to lessen the impacts of industrial animal agriculture.

Supermarket shelves and fast food restaurants across the US are serving up vegan burgers and meatballs and plant-based chicken nuggets are showing consumers there is an alternative to relying on animal-based protein.

But a quiet revolution is also taking place in labs, where scientists are working to cultivate meat and seafood grown from cells, with the potential to reduce demand for industrial animal agriculture even further.

Heres how the process works: Stem cells are taken from the muscle of an animal, usually with a small biopsy under anesthesia, then theyre put with nutrients, salts, pH buffers, and growth factor and left to multiply. Finessing the technology and getting the cost to an affordable level is happening at a slower pace than the plant-based industry, but a number of start-ups are nevertheless aiming to get their products on the market soon.

Memphis Meats' pan-seared cell-based chicken with sugar snap peas.

Cell-based meat (also known as cultured, cultivated, slaughter-free, cell-cultured, and clean meat) will be a common sight in supermarkets across the west in the next three years, according to theInstitute of the Future in Palo Alto. California-based Memphis Meats made headlines for its world-first cell-based meatballs four years ago, and iscurrently building a pilot plantto produce its cultured beef, chicken, and duck on a bigger scale with plans to launch more plants around the world.

And it isnt the only cell-based meat start-up in the The Golden State. Theres the recently formed San Francisco-basedArtemys Foods, co-founded by biochemist Jess Krieger, who has spent the past six years working at Kent State University in Ohio growing cell-based meat in a lab, Berkeley-basedMission Barns, focusedon creating animal fat, which it has mixed with other ingredients to make duck sausages, and San Diego-based BlueNalu, a startup developing seafood from fish cells through a process called cellular aquaculture.

Close up of BlueNalu's whole-muscle, cell-based yellowtail, beer-battered and deep-fried for fish ... [+] tacos.

But innovation isnt limited to the US its happening across the world.The global cell-based meat market is predicted to be worth$15.5m by 2021 and $20m by 2027,according to analysis.One report estimates that35% of all meat will be cultured by 2040.

While estimates vary, one study found that cell-based beef is projected to use 95 per cent fewer global greenhouse gas emissions, 98 per cent less land use and up to half as much energy. It also significantly reduces the amount of antibiotics needed, which are widely used in agriculture and contribute hugely to worseningantibiotic resistance. And since the animal cells are extracted humanely and grown in a facility rather than within the animals themselves, cell-based meat has the potential to all but eliminate animal suffering.

The industry has made huge progress since the first cell-based hamburger was unveiled in 2013 in London byDutch stem cell researcher Mark Post, chief scientific officer atDutch companyMosa Meat.While this was a huge achievement, it also showed the world how far the industry had to go before commercially viable cell-based meat could be a reality. It cost $325,000 to make, and wasnt totally animal-free, as most of the burgers muscle strands were grown with fetal bovine serum, which comes from blood drawn from bovine fetuses.

In the intervening years, Mosa Meat has made several breakthroughs, and aims to bring the price down to a commercial price. It now doesnt require fetal bovine serum, and hasdeveloped a process thatallows industrial scale production.

Cell-based tartar (raw minced beef, commonly eaten in some of the Northern European countries), ... [+] created by Mosa Meat.

Also in the Netherlands, start-up Meatable has recently raised 9m to help reduce costs and scale-up production of its beef and pork. It aims to havean industry-scale plant by 2025,and will have a small-scale bioreactor the machine where cell-growth takes place - this year.Meatables cofounder Krijn de Nood hopes tounveil its first prototype this summer.

Elsewhere in Europe, the UKs Higher Steaks is growing stem cells for the production of mince for pork sausages. Instead of using fetal bovine serum,the company uses protocols exclusively licensed to itby its collaborators, the University of Minnesota, that allow it to reprogram stem cells into muscle and fat tissues.

Instead of adult stem cells, it uses induced pluripotent stem cells, which means they have an infinite supply as the cells proliferate infinitely. With adult stem cells, researchers have to go to the animal every time they need a new batch.

AndSpains Cubiq Foodsis producing cell-based fat, which is used to enhance the flavor of food and enrich it with essential fatty acids, such as omega-3.

But when it comes to cell-based meat, all eyes are on Israel, where a number of start-ups likeFuture Meat Technologies and SuperMeat are making huge progress. The countrys interest in cell-based meat has also been attributed to its thriving vegan culture.

Comparison of Future Meat Technologies' cell-based chicken (left) to of farm-raised chicken (right). ... [+]

Future Meat Technologies, founded in 2018, has shortened the manufacturing process to two weeks, with a patent-pending method they say allows for higher production yields of cell-based beef. The start-up's technologies enable producers, farmers and retailers to manufacture biomass and process it locally. The company hopes toget cost down to $10 per poundby 2022.

As for SuperMeat, it is developing cell-based meat from chicken cells (it claimed during its launch in 2016 that it wasthe first company to work on clean chicken productsfor mass production). One of Europe's largest poultry producers,PHW-Gruppe formed a partnershipwith SuperMeat in 2018. We believe 2020 will be the tipping point for the cultivated meat industry, once the proof of scale will be introduced to the world, says Shir Friedman, Co-Founder and Chief Communications Officer of the company. SuperMeat is excited to take a lead part in this historical event."

An illustration of SuperMeat's cell-based meat cultivators of the future.

Another Israeli start-up,Aleph Farms, created the worlds first cell-based steak at the end of 2018.It was co-founded only one year prior together with The Kitchen Hub from the Strauss Group, and with Professor Shulamit Levenberg of the Technion Institute of Technology. And in fall of 2019,Aleph Farmssuccessfully3D printedmeat on the International Space Station. Our experiment ofbioprintingmeat in space... consisted of printing a small-scale muscle tissue using 3D Bioprinting Solutions bioprinting technology, says Yoav Reisler, External Relations Manager for the company. The proof of concept sought to assess the potential of producing cultivated meat in a zero-gravity environment away from land and local water resources. Our approach for cultivating beef steaks is imperative to the experiment, as it relies on mirroring the natural process of tissue regeneration that happens in a cows body but under controlled and animal-free conditions. Our overarching goal is to produce meat products that have a significantly reduced ecological impact and this was a milestone in towards achieving that. Earlier this month, Aleph Farms announced plans to open an educational complex next to its production facility to provide the general public a more in-depth view of how cell-based meat is grown.

Thin-cut beef steaks cultivated by Aleph Farms.

Also in Israel,BioFood Systemsaims to produce beef products using bovine embryonic stem cells. It also hopes to scale up technology that it can license globally toenable meatmanufacturers to produce their own cell-based meat.

But other parts of the world arent far behind Israel, including Asia. Singaporean Shiok Meats is working on bringing cell-based based crustaceans (shrimp, crab and lobster) to market, and says its the first company of its kind in Singapore and South-East Asia. It hopes to have a commercially viable product in the next few years, and is currently researching and developing.

Shiok Meats cell-grown shrimp dumplings.

And in Japan, meat producer Toriyama and its export agent, Awano Food Group has partnered with JUST to grow, distribute and sell its cell-based wagyu beef worldwide.

JUST doesn't yet have images of its cell-based wagyu because its still in early stage R&D, but it ... [+] may one day look like this animal-based piece of Wagyu beef steak seen here.

In-between Asia and Europe, innovation is also happing in Turkey. Biftek is the first and still the only companydeveloping cultured meat in the country. It uses a plant-based formulation, made up of 44 proteins, in place of fetal bovine serum. Founder Can Akcali said in a recent interview that the media in Turkey is showing a growing interest in its work, and cell-based meat more widely.

Since the first cell-based unveiling of a cell-based burger in 2013, scientists have been flocking to labs in a race to iron out numerous teething problems and be the first to make a commercially viable cell-based meat product. Meanwhile, private investment into the industry has soared. Last year, twelve companiesraised $50 million in 14 deals double the amount of 2018. US-based Memphis Meats raised $22 million, Spain's Cubiq Foods raised $14 million and Mosa Meat drew in $9 million.

Memphis Meats now plans to build a pilot production facility,thanks to additional investments in January this yearfrom Cargill and Tyson Foods, as well as high-profile investors Bill Gates, Richard Branson, and Kimbal Musk.

Ido Savir, SuperMeats chief executive, said Mosa Meat introduced the concept of cell-based meat to the world, and that the main challenge start-ups are still facing is proof of scaling up production to a commercially viable size that's cost-efficient. Once these hurdles are overcome, it will be a much smoother process to get cell-based meat on shelves. At the moment, cell-based products are being prototyped in labs - but once scientists have finessed the process and the cost, theyre produced at scale and can grow in facilities like any other food.

Many cell-based start-ups expect to get their products to market in the next few years. Whether or not they are actually able to meet that projection is an open question. I worry most startups in the cultured meat space are overestimating their short-term timeline to get to market and underestimating their potential long-term impact on completely redesigning our food system from the cell-level up, says Max Elder, Research Director in the Food Futures Lab at Institute for the Future. Regardless of the timeline, one thing is clear: we desperately need to undo the damage industrialized animal agriculture is wreaking on our communities, animal, and planet. While it may indeed be unwise to count our cultured chickens before they hatch, especially in light of the urgent challenges we are facing, we can no doubt expect more innovation in the coming years. Perhaps one day - even if not in the near future - all the meat on our plates will indeed be slaughter-free.

Read this article:
Will Cultured Meat Soon Be A Common Sight In Supermarkets Across The Globe? - Forbes